Investing
First Look Analysts Research Calls for Thursday, January 19
Published:
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> CureVac (CVAC) upgraded to Buy from Neutral at UBS; tgt raised to $18
Downgrades:
> Cognizant Tech (CTSH) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $60
> DXC Technology (DXC) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $28
Others:
> Alpine Immune Sciences (ALPN) initiated with an Overweight at Morgan Stanley; tgt $17
> CF Industries (CF) initiated with an Overweight at Wells Fargo; tgt $110
> Corteva (CTVA) initiated with an Overweight at Wells Fargo; tgt $78
> FMC Corp (FMC) assumed with an Overweight at Wells Fargo; tgt $148
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
